CAS 55481-88-4
:Mollugin
- 2H-naphtho[1,2-b]pyran-5-carboxylic acid, 6-hydroxy-2,2-dimethyl-, methyl ester
- Methyl 6-hydroxy-2,2-dimethyl-2H-benzo[h]chromene-5-carboxylate
- Rubimaillin
- Smb 00431
- Mollugin
- 2H-Naphtho[1,2-b]pyran-5-carboxylic acid
- Mollugin/rubiMaillin
- 6-Hydroxy-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5-carboxylic acid methyl ester
- Mollugin, 98%, from Rubia cordifolia L.
- 6-hydroxy-2, 2-dimethyl-, methylester
- RUBIMAILLIN; MOLLUGIN
- 2-DiMethyl-6-hydroxy-2H-naphtho[1,2-b]pyran-5-carboxylic acid Methyl ester
- 6-Hydroxy-2,2-dimethyl-2H-benzo[h]chromene-5-carboxylic Acid Methyl Ester
- 2,2-Dimethyl-6-hydroxy-2H-naphtho[1,2-b]pyran-5-carboxylic acid methyl ester
- MOLLUGIN(SH)
- Voir plus de synonymes
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
Mollugin
CAS :Formule :C17H16O4Degré de pureté :>98.0%(HPLC)Couleur et forme :White to Yellow to Orange powder to crystalMasse moléculaire :284.31Methyl 6-Hydroxy-2,2-Dimethyl-2H-Benzo[H]Chromene-5-Carboxylate
CAS :Methyl 6-Hydroxy-2,2-Dimethyl-2H-Benzo[H]Chromene-5-CarboxylateFormule :C17H16O4Degré de pureté :99%Masse moléculaire :284.31Mollugin
CAS :Mollugin is a JAK2 inhibitor and inhibits LPS-induced inflammatory responses by blocking the activation of the JAK-STAT pathway. Mollugin may be a novel therapeutic candidate for bone loss-associated disorders including osteoporosis, rheumatoid arthritis, and periodontitis. Mollugin has anticancer efficacy, can modulate the HER2, HO-1, Nrf2 , and NF- κB pathways.Formule :C17H16O4Degré de pureté :95%~99%Masse moléculaire :284.311Mollugin (Standard)
CAS :Mollugin (Standard) is the standard for Mollugin. Mollugin selectively inhibits the NLRP3 inflammasome, coordinately regulates inflammation and oxidative stress to promote regeneration, and induces ferroptosis in NSCLC while inhibiting tumor growth in vivo.Formule :C17H16O4Masse moléculaire :284.31Methyl 6-hydroxy-2,2-dimethyl-2H-benzo[h]chromene-5-carboxylate
CAS :Formule :C17H16O4Degré de pureté :%Couleur et forme :SolidMasse moléculaire :284.3065Mollugin
CAS :Mollugin could be a JAK2 inhibitor, anti-inflammatory, chemotherapeutic agent in OSCCs, bone disorder therapy, and modulates HER2 in cancer.Formule :C17H16O4Degré de pureté :99.87% - ≥95%Couleur et forme :SolidMasse moléculaire :284.31Mollugin
CAS :Oxygen-heterocyclic compoundFormule :C17H16O4Degré de pureté :≥ 95.0 % (HPLC)Masse moléculaire :284.31Mollugin
CAS :Methyl 6-hydroxy-2,2-dimethyl-2H-benzo[h]chromene-5-carboxylateFormule :C17H16O4Degré de pureté :98+%Masse moléculaire :284.31Methyl 6-hydroxy-2,2-dimethyl-2H-benzo[h]chromene-5-carboxylate
CAS :Degré de pureté :≥98%(HPLC)Masse moléculaire :284.3110046Mollugin
CAS :Produit contrôléApplications Mollugin is an anti-tumor agent inducing apoptosis and autophagy in various cancer models.
References Zhang, L. et al.: Biochem. Biophys. Res. Comm., 450, 247 (2014); Idhayadhulla, A. et al.: Bioorg. Chem., 52, 77 (2014);Formule :C17H16O4Couleur et forme :NeatMasse moléculaire :284.31Mollugin
CAS :Mollugin is a bioactive compound, which is derived from the plant Rubia cordifolia. As a phytochemical, it is part of the anthraquinone family, isolated through extraction processes from the root of its source plant. Its mode of action involves modulating various biochemical pathways, notably exhibiting anti-inflammatory, anticancer, and antioxidant activities. These effects are primarily mediated through the inhibition of specific enzymes and signaling pathways, including the NF-κB and MAPK pathways, which are central to inflammatory and cancer processes.
Degré de pureté :Min. 95%











